Matrixx Appoints Scerene Healthcare Executive To Lead Turnaround
This article was originally published in The Pink Sheet Daily
Executive Summary
M’lou Arnett talks about how her experience, including designing the “Mr. Mucus” advertising icon for the Mucinex cough treatment line, has prepared her for the challenge of growing Matrixx’s revenues in the wake of removing the Zicam gel and swab products from the market.
You may also be interested in...
Zicam Maker Matrixx Settles With Shareholders Over H.I.G. Buyout
Matrixx Initiatives remains mired in multiple lawsuits despite settling litigation with shareholders over the firm’s handling of its 2010 buyout.
Matrixx Bought By Private Equity Firm H.I.G., Settles Personal Injury Lawsuits
Matrixx Initiatives announced Dec. 14 private equity firm H.I.G. Capital will acquire the Scottsdale, Ariz.-based maker of Zicam cough/cold products for approximately $75.2 million.
FDA Uses "Unusual" Action To Get Matrixx's Zicam Off The Market
In a rare action, FDA simultaneously alerted consumers not to use Matrixx Initiatives' intranasal Zicam products because of potential safety problems and warned Matrixx to remove the products from market without first consulting with the firm